Success Metrics

Clinical Success Rate

100.0%

Based on 3 completed trials

Completion Rate

100%(3/3)

Active Trials

0(0%)

Results Posted

33%(1 trials)

Phase Distribution

Ph not_applicable

60%

Ph phase_2

20%

Ph early_phase_1

20%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Early Phase 1First-in-human

1(20.0%)

Phase 2Efficacy & side effects

1(20.0%)

N/ANon-phased studies

3(60.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(3)

Other(1)

Detailed Status

Completed3

Not yet recruiting1

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 2

Trials by Phase

Early Phase 11 (20.0%)

Phase 21 (20.0%)

N/A3 (60.0%)

Trials by Status

not_yet_recruiting120%

completed360%

unknown120%

Recent Activity

0 active trials

Showing 5 of 5

not_yet_recruitingnot_applicable

Effect of Continuous Positive Airway Pressure (CPAP) Versus Auto-titrating Continuous Positive Airway Pressure (APAP) on Resistant Hypertension (HTN) and Arterial Stiffness

NCT01044355

Clinical Trials (5)

Showing 5 of 5 trials

NCT06413134Not Applicable

KPAP Adherence Crossover Study

Not Yet Recruiting

NCT03088800Phase 2

IBUPAP Study for Pain Management in Children

Completed

NCT02721329Not Applicable

Evaluation of APAP With SensAwake in OSA and Insomnia Patients

Completed

NCT03878693Early Phase 1

4-methylpyrazole and Acetaminophen Metabolism

Completed

NCT01044355Not Applicable

Effect of Continuous Positive Airway Pressure (CPAP) Versus Auto-titrating Continuous Positive Airway Pressure (APAP) on Resistant Hypertension (HTN) and Arterial Stiffness

Unknown

All 5 trials loaded

Drug Details

Intervention Type: DEVICE
Total Trials: 5